This HTML5 document contains 81 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n9http://caligraph.org/ontology/MeSH_code_(D02)
n14http://en.wikipedia.org/wiki/%CE%93
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://en.wikipedia.org/wiki/Category:
n16http://en.wikipedia.org/wiki/List_of_MeSH_codes_(D02)
n11http://en.wikipedia.org/wiki/List_of_drugs:_Fm%E2%80%93
n8http://caligraph.org/ontology/Drug:
n12http://en.wikipedia.org/wiki/List_of_drugs:
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
clgohttp://caligraph.org/ontology/
n6http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
clgr:Brain_tumor
clgo:medication
clgr:Furosemide
Subject Item
clgr:Hypercalcaemia
clgo:treatment
clgr:Furosemide
Subject Item
clgr:Furosemide
rdf:type
clgo:Loop_diuretic clgo:Nephrotoxin clgo:Chemical_substance_for_emergency_medicine clgo:Human_blood_component clgo:World_Health_Organization_essential_medicine clgo:Medical_mnemonic n8:_La n9: clgo:Anthranilic_acid owl:NamedIndividual clgo:Carbonic_anhydrase_inhibitor clgo:Equine_medication clgo:Furan clgo:Compounds_with_carbon_number_12 clgo:GABAA_receptor_negative_allosteric_modulator clgo:Sulfonamide clgo:NMDA_receptor_antagonist clgo:Glycine_receptor_antagonist clgo:Chloroarene clgo:Drug_banned_by_the_World_Anti-Doping_Agency
rdfs:label
Furosemide
owl:sameAs
dbr:Furosemide
prov:wasDerivedFrom
n5:Nephrotoxins n6:Lithium_toxicity n6:Acyanotic_heart_defect n6:List_of_compounds_with_carbon_number_12 n6:IARC_group_3 n5:Chloroarenes n6:List_of_sulfonamides n6:List_of_medical_mnemonics n5:Furans n6:List_of_human_blood_components n5:Loop_diuretics n5:Carbonic_anhydrase_inhibitors n6:Paramedic n6:WHO_Model_List_of_Essential_Medicines_for_Children n6:Sanofi n6:List_of_drugs_by_year_of_discovery n6:Pimobendan n6:Aliskiren n11:Ft n5:Anthranilic_acids n5:Sulfonamides n5:NMDA_receptor_antagonists n12:_La n6:Antihypertensive_drug n5:GABAA_receptor_negative_allosteric_modulators n6:Sulfanilamide n6:Gentamicin n5:Equine_medications n14:-Aminobutyric_acid n6:List_of_drugs_banned_by_the_World_Anti-Doping_Agency n5:Chemical_substances_for_emergency_medicine n5:World_Health_Organization_essential_medicines n6:Loop_diuretic n5:Glycine_receptor_antagonists n6:Hypercalcaemia n16: n6:Multidrug_resistance-associated_protein_2 n6:List_of_veterinary_drugs n6:Hyperkalemic_periodic_paralysis n6:Creatine n6:WHO_Model_List_of_Essential_Medicines
skos:prefLabel
Furosemide
skos:altLabel
furosemide Furosemide glucuronide Lasix
clgo:alternativeName
Lasix, others
clgo:bioavailability
43.0
clgo:casNumber
54-31-9
clgo:chEBI
47426
clgo:chEMBL
35
clgo:drugbank
DB00695
clgo:fdaUniiCode
7LXU5N7ZO5
clgo:kegg
D00331
clgo:medlinePlus
a682858
clgo:pubchem
3440
Subject Item
clgr:Ascites
clgo:medication
clgr:Furosemide
Subject Item
clgr:Hypokalemia
clgo:medicalCause
clgr:Furosemide